Clinical trial

A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

NCT04636762

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Radiation Therapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-06-01

PhasePHASE2

Conditions

Extensive-stage Small Cell Lung Cancerunresolved

Interventions

Radiation TherapyPROCEDURE

Sponsors & collaborators

Second Xiangya Hospital of Central South Universitylead sponsor

Hunan Cancer Hospitalcollaborator

Mapped research locations

ChangshaHunan, China2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04636762 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.